Hepatosplenic T cell lymphoma: Difference between revisions
No edit summary |
No edit summary |
||
Line 17: | Line 17: | ||
{{CMG}} | {{CMG}} | ||
'''''Synonyms and Keywords:''''' Hepatosplenic γδ T-cell lymphoma | '''''Synonyms and Keywords:''''' Hepatosplenic γδ T-cell lymphoma, Hepatosplenic gamma delta T-cell lymphoma | ||
==[[Hepatosplenic T cell lymphoma overview|Overview]]== | ==[[Hepatosplenic T cell lymphoma overview|Overview]]== |
Revision as of 13:30, 24 February 2016
For patient information, click here
Hepatosplenic T cell lymphoma | |
ICD-O: | 9716/3 |
---|
Hepatosplenic T cell lymphoma Microchapters |
Differentiating Hepatosplenic T cell lymphoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Hepatosplenic T cell lymphoma On the Web |
American Roentgen Ray Society Images of Hepatosplenic T cell lymphoma |
Directions to Hospitals Treating Hepatosplenic T cell lymphoma |
Risk calculators and risk factors for Hepatosplenic T cell lymphoma |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and Keywords: Hepatosplenic γδ T-cell lymphoma, Hepatosplenic gamma delta T-cell lymphoma
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Epidemiology and Demographics
Risk Factors
Screening
Differentiating Hepatosplenic T cell lymphoma from other Diseases
Natural History, Complications and Prognosis
Diagnosis
Staging | History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies